Soleus Capital Management’s Guardant Health GH Stock Holding History

Soleus Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-17,500	Closed	-$2.17M	–	76
2021 Q2	$2.17M	Buy	+17,500	New	+$2.35M	0.33%	50
2020 Q1	–	Sell	-4,900	Closed	-$382K	–	54
2019 Q4	$382K	Buy	+4,900	New	+$353K	0.37%	41

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Soleus Capital Management's GH Position: Q3 2021 in Review

Soleus Capital Management sold out of Guardant Health (GH) in Q3 2021, closing a stake of 17,500 shares — an estimated $2.17M sold.

Soleus Capital Management first reported a position in GH in Q4 2019 and held it in 2 quarters. The position peaked at $2.17M in Q2 2021. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

Soleus Capital Management reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
Soleus Capital Management sold 17,500 Guardant Health shares in Q3 2021, an estimated $2.17M.
Soleus Capital Management first reported a position in Guardant Health in Q4 2019 and held it in 2 quarters.
Soleus Capital Management's Guardant Health position peaked at $2.17M in Q2 2021.
374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Soleus Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.